Abstract:Tetrahydropyrido [1,2-a]isoindolone derivatives are potent inhibitors of glycogen synthase kinase 3 beta (GSK3 beta) instead of homologous cyclin-dependent kinase 5 (CDK5). Molecular docking, molecular dynamics simulation, and MM/PBSA energy calculation are utilized to reveal the kinase inhibitors' selective mechanism at the molecular level for improving selectivity. Dynamic cross-correlation map (DCCM) analysis is applied to study the effect of the inhibitor on the interactions between each residue in CDK5 and GSK3 beta. The results of molecular docking indicate that the binding modes of three inhibitors with two kinases are especially similar, and residues in the binding pockets of two kinases are aligned with each other based on the sequence comparing analysis of crystal structures. The analysis of Root Mean Square Deviation (RMSD) with little fluctuation underlies the stability and reliability of systems. Its values of CDK5 (similar to 0.15 nm) are less than GSK3 beta (similar to 0.17 nm), and the inhibitor with higher value holds stronger flexibility and conformational changes of kinases. In terms of energies, the electrostatic and van der Walls energies are the major interactions for differentiating the activity between the same inhibitor and two kinases. And the polar solvation energy plays pivotal role in discriminating the selectivity of kinase inhibitor. The residue decomposition indicates that the residues Glu97 and Thr138 of GSK3 beta are the key residues for differentiating the inhibitor selectivity. On the other hand, in the aspect of inter-residue interaction in one kinase, results indicate that the dynamic correlation of residues is different during the binding process of CDK5 and GSK3 beta with inhibitors. The correlation of Thr138 in the hinge domain of GSK3 beta with that of residues Val135-Gln206 is positive, while the correlation of Gln85 and Cys83 similar to Ala150 in CDK5 is unclear, which is a key factor to distinguish inhibitor selectivity.

Exploring the Selectivity of Tetrahydropyrido[1,2-a]isoindolone Derivatives to GSK3 beta and CDK5 by Computational Methods

Understanding the Selectivity of Inhibitors Toward PI4KIIIα and PI4KIIIβ Based Molecular Modeling

Molecular Principle of the Cyclin-Dependent Kinase Selectivity of 4-(Thiazol-5-yl)-2-(phenylamino) Pyrimidine-5-carbonitrile Derivatives Revealed by Molecular Modeling Studies.

An Insight into the Inhibitory Selectivity of 4-(Pyrazol- 4-Yl)-pyrimidines to CDK4 over CDK2

Study on Selectivity of Inhibitor BD2 for PKA over PKC beta II

Binding Mechanism of CDK5 with Roscovitine Derivatives Based on Molecular Dynamics Simulations and MM/PBSA Methods.

Effect of Substituents in Different Positions of Aminothiazole Hinge-Binding Scaffolds on Inhibitor–CDK2 Association Probed by Interaction Entropy Method

Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study.

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with alpha-Substituent Electrophiles Targeting Cysteine

Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations

Theoretical Studies on Beta and Delta Isoform-Specific Binding Mechanisms of Phosphoinositide 3-Kinase Inhibitors.

Discovery and Computational Studies of Potent Covalent Kinase Inhibitors with -Substituent Electrophiles Targeting Cysteine

Study on improving the selectivity of compounds that inhibit two PI3Ks (gamma and delta)

Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.

Molecular Dynamic Simulations Give Insight into the Mechanism of Binding Between 2-Aminothiazole Inhibitors and CDK5

Cooperation of structural motifs controls drug selectivity in cyclin-dependent kinases: an advanced theoretical analysis

Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3β (GSK-3β) inhibitors

A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3β

Exploring the Selective Mechanism of Inhibitors Towards Different Subtypes of Class I PI3K

Dissection of the Difference Between the Group I Metal Ions in Inhibiting GSK3β: a Computational Study.

In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation